How is Efficacy Measured in Preclinical Cancer Studies?
Efficacy is typically assessed by measuring the ability of a treatment to inhibit tumor growth or kill cancer cells. Common metrics include:
Reduction in Tumor Size: Measured using imaging techniques or calipers in animal models. Cell Viability Assays: In vitro tests like MTT or ATP assays to measure cell survival. Biomarker Analysis: Assessing levels of specific biomarkers that indicate treatment response.
